← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Montefiore Medical Center
Bronx, NY
$4,348,219
Total funding
6
Grants
Funding over time
peak $2.5M · FY2005–12$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
DOD$4,348,219 · 5
NIH$0 · 1
By mechanism
—$4,348,219 · 5
N01$0 · 1
Investigators at Montefiore Medical Center
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
MEDICAL SURVEILLANCE TECHNOLOGY - CLINICAL LOOKING GLASS$2,459,000
· FY2008 · Department of the Army
MEDICAL SURVEILLANCE TECHNOLOGY - "CLINICAL LOOKING GLASS"$700,000
· FY2010 · Department of the Army
APPLIED HEALTH INFORMATION TECHNOLOGIES-CLINICAL LOOKING GLASS(CLG)$459,841
· FY2012 · Department of the Army
THE ROLE OF ANTIPHOSPHOLIPID ANTIBODIES IN TUMOR PROGRESSION TO MALIGNANCY IN BREAST CANCER$366,430
· FY2010 · Department of the Army
THE ROLE OF ANTIPHOSPHOLIPID ANTIBODIES IN TUMOR PROGRESSION TO MALIGNANCY IN BREAST CANCER$362,948
· FY2010 · Department of the Army
EARLY THERAPUETICS DEVELOPMENT WITH PHASE 2 EMPHASIS-261017103$0
N01 · FY2004 · CA
EARLY THERAPUETICS DEVELOPMENT WITH PHASE 2 EMPHASIS-261017103$0
N01 · FY2003 · CA
EARLY THERAPUETICS DEVELOPMENT WITH PHASE 2 EMPHASIS-261017103$0
N01 · FY2002 · CA
EARLY THERAPUETICS DEVELOPMENT WITH PHASE 2 EMPHASIS-261017103$0
N01 · FY2005 · CA